Article
Additional-structural-chromosomal aberrations are associated with inferior clinical outcome in patients with hyperdiploid multiple myeloma: a single-institution experience.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc - 1 Jun 2017
Carballo-Zarate Adrian A, Medeiros L Jeffrey, Fang Lianghua, Shah Jatin J, Weber Donna M, Thomas Sheeba K, Manasanch Elisabet E, Hao Suyang, Shen Qi, Orlowski Robert Z, Lin Pei, Lu Xinyan
Abstract excerpt
Multiple myeloma is cytogenetically heterogeneous and a hyperdiploid karyotype is considered currently to have standard risk. In this study, we investigated the clinical impact of additional-structural-chromosomal aberrations assessed by chromosome analysis in 284 patients with a hyperdiploid karyotype that were subdivided into four groups based on the complexity of additional-structural-chromosomal aberrations:...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
